Trial Profile
A Randomized Controlled Trial of Oseltamivir in Outpatients With Chronic Pulmonary Disease: a Pilot Study
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 20 Apr 2018
Price :
$35
*
At a glance
- Drugs Oseltamivir (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 15 Mar 2018 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 07 Nov 2014 New trial record